[1] |
ELIAS M D, NARULA S, CHU A S. Acute disseminated encephalomyelitis following meningoencephalitis:case report and literature review[J]. Pediatr Emerg Care, 2014, 30(4):254-256. DOI: 10.1097/PEC.0000000000000107.
|
[2] |
|
[3] |
DUIGNAN S, WRIGHT S, ROSSOR T,et al. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes[J]. Dev Med Child Neurol, 2018, 60(9):958-962. DOI: 10.1111/dmcn.13703.
|
[4] |
HENNES E M, BAUMANN M, SCHANDA K,et al. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome[J]. Neurology, 2017, 89(9):900-908. DOI: 10.1212/WNL.0000000000004312.
|
[5] |
WATERS P, FADDA G, WOODHALL M,et al. Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes[J]. JAMA Neurol, 2020, 77(1):82-93. DOI: 10.1001/jamaneurol.2019.2940.
|
[6] |
WANG X, ZHAO R B, YANG H F,et al. Clinical analysis of myelin oligodendrocyte glycoprotein antibody-associated demyelination in children:a single-center cohort study in China[J]. Mult Scler Relat Disord, 2022, 58:103526. DOI: 10.1016/j.msard.2022.103526.
|
[7] |
|
[8] |
董谷一,李斯博,肖向建. 髓鞘少突胶质细胞糖蛋白抗体与儿童获得性脱髓鞘综合征[J]. 脑与神经疾病杂志,2020,28(1):61-64.
|
[9] |
ZHOU J, LU X P, ZHANG Y,et al. Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination[J]. Mult Scler Relat Disord, 2019, 28:4-10. DOI: 10.1016/j.msard.2018.12.001.
|
[10] |
YAZBECK E, MAUREY H, LEROY C,et al. Progressive leukodystrophy-like demyelinating syndromes with MOG-antibodies in children:a rare under-recognized phenotype[J]. Neuropediatrics, 2021, 52(4):337-340. DOI: 10.1055/s-0041-1726289.
|
[11] |
HACOHEN Y, MANKAD K, CHONG W K,et al. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children[J]. Neurology, 2017, 89(3):269-278. DOI: 10.1212/WNL.0000000000004117.
|
[12] |
FOIADELLI T, GASTALDI M, SCARANZIN S,et al. Seizures and myelin oligodendrocyte glycoprotein(MOG)antibodies:two paradigmatic cases and a review of the literature[J]. Mult Scler Relat Disord, 2020, 41:102011. DOI: 10.1016/j.msard.2020.102011.
|
[13] |
RAMANATHAN S, O'GRADY G L, MALONE S,et al. Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children[J]. Dev Med Child Neurol, 2019, 61(5):610-614. DOI: 10.1111/dmcn.14032.
|
[14] |
DALE R C, TANTSIS E M, MERHEB V,et al. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton[J]. Neurol Neuroimmunol Neuroinflamm, 2014, 1(1):e12. DOI: 10.1212/NXI.0000000000000012.
|
[15] |
BOESEN M S, JENSEN P E H, BORN A P,et al. Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008-2018:a nationwide,population-based cohort study[J]. Mult Scler Relat Disord, 2019, 33:162-167. DOI: 10.1016/j.msard.2019.06.002.
|
[16] |
MARTINEZ-HERNANDEZ E, GUASP M, GARCÍA-SERRA A,et al. Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies[J]. Neurology, 2020, 94(22):e2302-2310. DOI: 10.1212/WNL.0000000000009239.
|
[17] |
FAN S Y, XU Y, REN H T,et al. Comparison of myelin oligodendrocyte glycoprotein(MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder(NMOSD)when they co-exist with anti-NMDA(N-methyl-D-aspartate)receptor encephalitis[J]. Mult Scler Relat Disord, 2018, 20:144-152. DOI: 10.1016/j.msard.2018.01.007.
|
[18] |
|
[19] |
JURYNCZYK M, MESSINA S, WOODHALL M R,et al. Clinical presentation and prognosis in MOG-antibody disease:a UK study[J]. Brain, 2017, 140(12):3128-3138. DOI: 10.1093/brain/awx276.
|
[20] |
PRÖBSTEL A K, DORNMAIR K, BITTNER R,et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis[J]. Neurology, 2011, 77(6):580-588. DOI: 10.1212/WNL.0b013e318228c0b1.
|